JCO oncology practice
Systemic Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder (Muscle-Invasive Bladder Cancer): Insights From Real-World Data.
Sarmad Sadeghi, Primo N Lara, Andrea Necchi, Parkash S Gill, Thomas W Flaig, Seth P Lerner, Monish Aron, Siamak Daneshmand
Published: 202510.1200/OP-25-00464
Abstract
PURPOSE: Neoadjuvant cisplatin-based chemotherapy before radical cystectomy (RC) has been standard-of-care treatment for muscle-invasive bladder cancer (MIBC) for over two decades. The study aimed to explore the outcomes of systemic therapy for MIBC.…
Preview only. Read the full abstract at the source